GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Bright Green
Shares of Bright Green, a company licensed to grow cannabis for research purposes in the US, are a highly speculative bet. Their price is driven not by financial performance, but by news of potential legalization and the company's business growth.
Share prices of companies in the market segment - Narco farm
Bright Green Corporation is one of the few companies in the US federally licensed to grow, produce, and sell cannabis for research and medical purposes. We've classified it as a "Drug Farm." The chart below shows the dynamics of this strictly regulated sector.
Broad Market Index - GURU.Markets
Bright Green is a company that cultivates and produces cannabis for medical and research purposes under a US federal license. As part of the GURU.Markets index, it represents the legal cannabis sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
BGXX - Daily change in the company's share price Bright Green
For Bright Green Corporation, a cannabis company, daily volatility reflects sensitivity to regulatory news. This metric is an indicator of progress in obtaining DEA approvals and business development.
Daily change in the price of a set of shares in a market segment - Narco farm
Bright Green Corporation cultivates and produces cannabis for research and pharmaceutical purposes under a DEA license. This sector is highly regulated and characterized by high volatility. The chart below shows average fluctuations in this industry, reflecting risks and investor sentiment.
Daily change in the price of a broad market stock, index - GURU.Markets
Bright Green is focused on producing cannabis for pharmaceutical research in the US. Its shares are highly volatile and dependent on regulatory decisions by the DEA and FDA. The dynamics of this sector add a unique and speculative element to the overall market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Bright Green
Bright Green Corporation's annual performance reflects its unique status as one of the few companies in the US with a federal license to cultivate cannabis for research. Its 12-month market capitalization is entirely dependent on its success in securing contracts with pharmaceutical companies and research institutes.
Annual dynamics of market capitalization of the market segment - Narco farm
Bright Green is one of the few companies federally licensed to cultivate cannabis in the US for research purposes. Its stock price is entirely speculative and based on investors' belief in its ability to capitalize on this unique position in the future, not on current financial performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bright Green, one of the few companies in the US with a federal license to cultivate cannabis for research purposes, occupies a unique niche. Its year-over-year market capitalization reflects investor expectations for potential business expansion as federal regulations evolve.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Bright Green
Bright Green is one of the few companies with federal approval to cultivate cannabis in the US for research purposes. Its monthly performance depends entirely on its ability to commercialize this unique status and on legislative developments.
Monthly dynamics of market capitalization of the market segment - Narco farm
Bright Green Corporation plans to become one of the largest legal producers of cannabis for medical and research purposes in the United States. This sector is fraught with enormous regulatory risks and intense competition. The chart below reflects the changing investor sentiment regarding cannabis legalization and commercialization.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bright Green produces cannabis for medical and research purposes under a DEA license. It is a unique company in the sector. Its stock price is driven not by the recreational market, but by demand from the pharmaceutical industry and changes in US federal legislation.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Bright Green
Shares of Bright Green, a company seeking to grow cannabis for pharmaceutical research, reflect expectations in this niche market. Weekly price action is highly volatile, driven by news of DEA licenses and partnerships with pharmaceutical companies. The chart below shows how short-term regulatory events impact the company.
Weekly dynamics of market capitalization of the market segment - Narco farm
Bright Green plans to become one of the largest legal producers of cannabis for medical and research purposes in the United States. Its future depends entirely on obtaining licenses and changes in federal legislation. The chart will demonstrate this high dependence on regulatory decisions.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Bright Green operates in the cannabis industry. This chart compares its weekly volatility to the market. It shows how dependent its stock is on legalization news and sector-specific events, often ignoring the overall sentiment of the S&P 500.
Market capitalization of the company, segment and market as a whole
BGXX - Market capitalization of the company Bright Green
Bright Green Corporation's valuation is a speculative bet on its unique status as a company federally authorized by the US government to cultivate cannabis for research purposes. Its market cap reflects expectations for future legislative changes, not current revenue.
BGXX - Share of the company's market capitalization Bright Green within the market segment - Narco farm
Bright Green's market share is unique—it's one of the few producers with a federal license to cultivate cannabis for research purposes in the United States. Its market share reflects its unique status and its potential to become a key supplier to the pharmaceutical industry.
Market capitalization of the market segment - Narco farm
This chart shows the total market capitalization of companies seeking to legally grow cannabis in the US at the federal level. Bright Green Group is one such project. The chart's dynamics reflect a high degree of speculation and dependence on future legislative changes.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of a project to legally grow high-purity marijuana. Bright Green's market cap is a bet on its unique status as a partner of the US Drug Enforcement Administration. The line shows how the company is attempting to secure its stake in the future of pharmaceutical cannabis.
Book value capitalization of the company, segment and market as a whole
BGXX - Book value capitalization of the company Bright Green
This graph illustrates Bright Green Corporation's physical assets. The line represents the combined value of its high-tech greenhouses and production facilities in New Mexico, built for the legal production of cannabis for research and pharmaceutical purposes under a DEA license.
BGXX - Share of the company's book capitalization Bright Green within the market segment - Narco farm
Bright Green's tangible assets include its high-tech greenhouses and production facilities for growing and processing cannabis for research and pharmaceutical purposes. The chart shows the company's stake in this unique and strictly regulated agritech infrastructure.
Market segment balance sheet capitalization - Narco farm
Compared to traditional pharmaceuticals, Bright Green, as a cannabis producer, is building its capital-intensive infrastructure from scratch. Its business requires greenhouses and processing facilities, which are the foundation of its "seed-to-sale" model.
Book value of all companies included in the broad market index - GURU.Markets
Bright Green Corporation aims to become one of the largest legal producers of cannabis for research and pharmaceutical purposes in the United States. The company's assets include massive greenhouses and production facilities in New Mexico. The graph below illustrates the planned physical scale of this emerging industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Bright Green
Bright Green Corporation builds high-tech greenhouses for the legal cultivation of cannabis for medical and research purposes under a federal license. Its balance sheet represents the value of these unique facilities. The chart below shows the premium the market pays for its special status and potential to supply pharmaceutical companies.
Market to book capitalization ratio in a market segment - Narco farm
Bright Green Corporation is one of the few companies in the US with federal approval to cultivate cannabis for research purposes. Its value is based on this unique status. This chart shows how the market values its potential relative to its current assets.
Market to book capitalization ratio for the market as a whole
Bright Green Corporation is one of the few companies in the US with a federal license to cultivate cannabis for research and pharmaceutical purposes. This chart shows how the market perceives the uniqueness of their license and their potential in a highly regulated industry.
Debts of the company, segment and market as a whole
BGXX - Company debts Bright Green
Bright Green, one of the few companies in the US with a federal license to cultivate cannabis for research purposes, is using the capital raised to build its facilities. This chart shows how the company is investing in creating a unique production facility, betting on the future growth of the pharmaceutical cannabinoid market.
Market segment debts - Narco farm
Bright Green aims to become one of the few federally licensed cannabis producers in the US for research and pharmaceutical purposes. This chart shows how its debt policy (or lack thereof) reflects the early stage of its project, which requires significant investment in the construction of secure production facilities.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Bright Green
Benson Hill uses artificial intelligence technologies to improve plant breeding, creating more nutritious and resilient crops. This is science-intensive agritech. The chart shows how the company is funding its long-term research, banking on a future revolution in food production.
Market segment debt to market segment book capitalization - Narco farm
Bright Green Corporation is building one of the world's largest federally licensed cannabis cultivation and production facilities for medical and scientific purposes in New Mexico. This chart compares its debt to the overall market capitalization of the entire sector. It shows how the company is financing its ambitious and capital-intensive project.
Debt to book value of all companies in the market
Bright Green Corporation aims to become one of the few legal DEA-licensed cannabis producers in the US for research and pharmaceutical purposes. This is a unique but risky business model. This graph of total market debt shows the company's risk appetite, which is important for assessing the company's ability to finance the construction of its secure facilities.
P/E of the company, segment and market as a whole
P/E - Bright Green
This metric for Bright Green, a company seeking to grow cannabis for pharmaceutical purposes, represents a speculative valuation. A price-to-earnings ratio (P/E) is not applicable. It's a bet on the company's ability to obtain all necessary DEA approvals and become a legitimate supplier to researchers and pharmaceutical companies.
P/E of the market segment - Narco farm
Bright Green Corporation is one of the few companies in the US federally licensed to cultivate, produce, and sell cannabis for research and pharmaceutical purposes. This chart reflects the overall assessment of the cannabis industry, providing insight into how the market views companies operating in the highly regulated medical and scientific segment.
P/E of the market as a whole
Bright Green Corporation is one of the few companies in the US federally licensed to cultivate, produce, and sell cannabis for research and pharmaceutical purposes. This chart, showing overall sentiment, provides insight into how investors view these unique and highly regulated companies in the cannabis sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Bright Green
Bright Green is one of the few companies in the US with a federal license to cultivate cannabis for research purposes. This graph reflects future revenue expectations, which depend on the development of the pharmaceutical cannabinoid market and potential license expansion.
%20P%2FE%20Bright%20Green&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Bright-Green&v=1772641124655 "Chart of the company's future (projected) P/E Bright Green")
Future (projected) P/E of the market segment - Narco farm
Bright Green Corporation aims to become one of the few federally licensed cannabis producers in the United States for research and pharmaceutical purposes. This chart reflects how the market views its unique yet risky business model. It compares expectations for Bright Green with other companies in the sector.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772641124699 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Bright Green Corporation cultivates and produces cannabis for medical and scientific purposes under federal licenses in the United States. The company's growth depends on legislative changes and growing demand from researchers and pharmaceutical companies. This graph, reflecting general sentiment, influences the investment climate in this highly specialized and regulated niche.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772641124818 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Bright Green
Bright Green Corporation is one of the few companies in the US that has received federal approval to cultivate cannabis for research and pharmaceutical purposes. Its financial model is still in its infancy. This chart illustrates the company's financial health, whose future profitability depends on the development of the legal market and scientific contracts.
Profit of companies in the market segment - Narco farm
Bright Green Corporation is one of the few companies in the US federally licensed to cultivate, produce, and sell cannabis for research and pharmaceutical purposes. This chart, showing overall profitability in the sector, reflects the company's unique position. Its success could pave the way for federal legalization and radically change the entire industry.
Overall market profit
Bright Green Corporation aims to become one of the largest legal producers of cannabis for medical and research purposes in the United States. The company has received a special permit from the Drug Enforcement Administration (DEA).
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Bright Green
Bright Green Corporation builds greenhouses for legal cannabis production for research and medical purposes in the United States. Future profit projections are speculative and depend on federal permits and contract awards.
%20profit%20of%20the%20company%20Bright%20Green&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Bright-Green&v=1772641125043 "Graph of future (projected) profit of the company Bright Green")
Future (predicted) profit of companies in the market segment - Narco farm
Bright Green Corporation aims to become a major producer of cannabis for medical and research purposes, holding a DEA license. This chart reflects profit projections for the entire legal cannabis industry. It shows analysts' expectations for the legal, yet strictly regulated, market and how the company positions itself within it.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772641125134 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Bright Green cultivates and produces cannabis for research and pharmaceutical purposes in the United States under a federal license. This is a unique and highly regulated niche. This chart is important because it reflects the investment climate. During periods of growth, funding for expanding production capacity and conducting research becomes more accessible.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772641125218 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Bright Green
Bright Green Corporation aims to become one of the largest legal producers of cannabis for research and pharmaceutical purposes in the United States. This chart, plotting its market capitalization against initial revenue, reflects its ambitious plans. It demonstrates investors' confidence in its ability to obtain all necessary permits and establish large-scale production.
P/S market segment - Narco farm
Bright Green Corporation aims to become one of the largest producers of medical and research cannabis in the United States, having received approval from the Drug Enforcement Administration (DEA). This chart shows how investors estimate revenue (or its future potential) in the legal cannabis sector, highlighting expectations for Bright Green's unique regulatory status.
P/S of the market as a whole
Bright Green Corporation is one of the few companies in the US federally licensed to cultivate, produce, and sell cannabis for research and pharmaceutical purposes. This chart, showing average revenue estimates, highlights the company's unique position in a highly regulated market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Bright Green
Bright Green Corporation plans to become one of the largest legal producers of cannabis for medical and research purposes in the United States. This chart shows the market's estimate of its potential future revenue. It reflects investors' confidence in its ability to obtain all necessary licenses and establish large-scale production.
%20P%2FS%20Bright%20Green&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Bright-Green&v=1772641125417 "The graph of the company's future (projected) P/S Bright Green")
Future (projected) P/S of the market segment - Narco farm
Bright Green Corporation is one of the few companies in the US federally licensed to cultivate, produce, and sell cannabis for research and pharmaceutical purposes. The chart shows the average estimated future sales for the cannabis sector, allowing for a better understanding of how the market views this unique, yet currently unprofitable, business model.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772641125436 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Bright Green (BGXX) is one of the few companies in the US federally licensed to cultivate cannabis for research and pharmaceutical purposes. Their potential depends on scientific advances and legislative changes. This timeline is not relevant to their unique and highly specialized business model.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772641125475 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Bright Green
Bright Green's revenue growth will reflect its operations in the federally regulated US cannabis market. The company plans to produce cannabis for scientific research and as a pharmaceutical raw material. Growth will depend on obtaining permits and securing contracts in this unique and niche market.
Sales of companies in the market segment - Narco farm
Bright Green Corporation is one of the few companies in the US that has received federal approval to cultivate cannabis for research and pharmaceutical purposes. Still in its early stages, it does not yet have significant revenue. Its future revenue will depend on contracts with pharmaceutical companies.
Overall market sales
Bright Green Corporation aims to become a major producer of cannabis for research and pharmaceutical purposes in the United States. The company's success depends on obtaining federal permits and the development of the legal cannabis market. This schedule, reflecting the overall state of the economy, influences the investment climate and the pace of regulatory change in new, emerging industries.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Bright Green
Bright Green Corporation aims to become one of the largest producers of federally approved medical and research cannabis in the United States. This timeline reflects long-term expectations for implementing its unique business model.
%20sales%20of%20the%20company%20Bright%20Green&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Bright-Green&v=1772641125545 "Schedule of future (projected) sales of the company Bright Green")
Future (projected) sales of companies in the market segment - Narco farm
Bright Green Corporation has received permission from the US Drug Enforcement Administration (DEA) to cultivate cannabis for research purposes. This chart shows the outlook for the cannabis sector. It reflects the gradual opening of the market to scientific and medical research, Bright Green's initial niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772641125555 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
This graph, reflecting regulatory trends and investments in new industries, is important for Bright Green. The company aims to become a major producer of cannabis for research and pharmaceutical purposes in the United States. Its success depends on federal legalization and the development of the legal market, which could accelerate in a stable economic environment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772641125586 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Bright Green
Bright Green Corporation is building one of the most technologically advanced greenhouses for the cultivation and production of cannabis for research and medical purposes under a federal license. This chart shows financial results during the construction phase. Future profitability depends on the successful launch of production and contract awards.
Market segment marginality - Narco farm
Bright Green is one of the few companies in the US with federal approval to cultivate cannabis for research and medical purposes. Future profitability will depend on its ability to become a key supplier to the pharmaceutical industry. This chart shows profitability in related sectors, providing context for assessing its unique position.
Market marginality as a whole
Bright Green Corporation aims to become a major legal producer of cannabis for research and pharmaceutical purposes in the United States. Its success depends entirely on obtaining all necessary licenses and demand from the scientific community. This timeline, reflecting the investment climate, affects the company's ability to finance the construction of its production facilities.
Employees in the company, segment and market as a whole
Number of employees in the company Bright Green
Bright Green Corporation aims to become a major producer of cannabis for medical and research purposes in the United States, licensed by the Drug Enforcement Administration (DEA). This timeline reflects the team's efforts to build and prepare production facilities for launch. This growth will mark the beginning of operations in a unique and highly regulated market segment.
Share of the company's employees Bright Green within the market segment - Narco farm
Bright Green Corporation is building one of the largest greenhouses in the United States for growing cannabis for research and medical purposes under a federal license. This chart shows the company's share of total employment in the legal cannabis industry. This reflects its unique status and ambitions to become a key supplier to the pharmaceutical industry.
Number of employees in the market segment - Narco farm
Bright Green Corporation is one of the few companies in the US federally licensed to cultivate, produce, and sell cannabis for research and pharmaceutical purposes. This chart, showing employment in the legal cannabis sector, is important. The growing number of scientists and agronomists in this highly regulated sector reflects the expansion of scientific research.
Number of employees in the market as a whole
Bright Green Corporation builds high-tech greenhouses for medical cannabis production according to US federal standards. This total employment chart reflects legalization and the growth of the emerging industry. A stable economy facilitates the development of regulatory frameworks and scientific research, which require the high-quality, standardized raw materials produced by Bright Green.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Bright Green (BGXX)
Bright Green (BGXX) is one of the few companies in the US with a federal DEA license to cultivate cannabis for research purposes. This business is capital-intensive (greenhouses, security) and has unique intellectual capital (license). This metric reflects the high valuation of this rare asset.
%20of%20the%20company%20Bright%20Green%20(BGXX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Bright-Green-BGXX&v=1772641125955 "Chart of market capitalization per employee (in thousands of dollars) of the company Bright Green (BGXX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Bright Green plans to become one of the largest producers of medical and research cannabis in the United States. Large-scale cultivation requires a significant staff. This chart allows investors to evaluate the company's future operating model and compare its potential effectiveness with existing market players.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772641125957 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Bright Green Corporation aims to become one of the largest legal producers of cannabis for research and pharmaceutical purposes in the United States. It is an agri-biotech business. This metric will reflect investor expectations for future growth and the company's ability to effectively manage both the cultivation process and its research programs.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772641125960 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Bright Green (BGXX)
Bright Green is one of the few companies in the US with a federal license (DEA) to grow cannabis for *research* purposes. It's not a recreational business. This chart likely reveals the company's deep losses: how much the company spends on each agronomist and scientist to set up this unique, strictly regulated operation, which doesn't yet have a large market.
%20Chart%20Bright%20Green%20(BGXX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Bright-Green-BGXX&v=1772641125972 "Company Profit Per Employee (in thousands of dollars) Chart Bright Green (BGXX)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Bright Green Corporation specializes in the cultivation and production of cannabis for medical and research purposes under US federal licenses. This chart shows the efficiency of their agricultural production. In this highly regulated industry, success depends on the ability to produce high-quality raw materials in compliance with all regulations and standards.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772641126000 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Bright Green (BGXX) is an American company licensed by the DEA to legally cultivate cannabis for research and pharmaceutical purposes. It's an agribusiness, but one with a high regulatory hurdle. This metric reflects how effectively the company is monetizing its (for now) unique status.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772641126014 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Bright Green (BGXX)
Bright Green Corporation is building greenhouses for cannabis production for research purposes under a DEA license. Revenue may be minimal during the construction and production phase. This timeline shows how the company will begin to monetize its unique federal license.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Bright-Green-BGXX&v=1772641126028 "Sales chart per company employee Bright Green (BGXX)")
Sales per employee in the market segment - Narco farm
Bright Green is one of the few companies in the US with federal approval (DEA) to cultivate cannabis for research and pharmaceutical purposes. It's an R&D agribusiness. This chart reflects their unique status. Their team's productivity lies in their ability to monetize this approval by supplying raw materials for scientific research.
Sales per employee for the market as a whole
Cracker Barrel (CBRL) operates a unique chain of restaurants and "old country store" stores, located primarily along highways across the United States. It's a hybrid of retail and food service. This chart demonstrates the efficiency of a highly labor-intensive business. Cracker Barrel's success depends on managing thousands of employees (servers, cooks, and salespeople) and maximizing sales in both the restaurant and the store.
Short shares by company, segment and market as a whole
Shares shorted by company Bright Green (BGXX)
Bright Green (BGXX) is one of the few companies in the US with a DEA license to grow cannabis for research. This chart tracks bearish bets. The shorts reflect the speculative nature of the bets: bears doubt the company will be able to monetize this license.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Bright-Green-BGXX&v=1772641126054 "Short Shares Chart for the Company Bright Green (BGXX)")
Shares shorted by market segment - Narco farm
Bright Green (BGXX) is one of the few companies in the US with federal (DEA) approval to cultivate cannabis for research purposes. The chart below shows the overall short position in the cannabis sector, demonstrating how skeptical investors are of the market.
Shares shorted by the overall market
Bright Green is one of the few companies with US federal approval to cultivate cannabis for R&D purposes. This chart illustrates the overall market pessimism. When investors are afraid, they flee hyped and speculative sectors. Shares of cannabis companies whose market is still in the gray zone are the first to sell off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Bright Green (BGXX)
Bright Green (BGXX) is one of the few companies in the US with federal approval to cultivate cannabis for research and pharmaceutical purposes. This unique, yet speculative, position is a unique one. This indicator measures the strength of speculative moves. It shows when the stock is "overheated" (above 70) or "oversold" (below 30) amid regulatory news.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Bright-Green-BGXX&v=1772641126076 "RSI 14 indicator chart for the company's stock Bright Green (BGXX)")
RSI 14 Market Segment - Narco farm
Bright Green is a company striving to become one of the few U.S. cannabis producers approved by the DEA for medical and research purposes. This chart measures the collective excitement or decline across the entire cannabis sector. It helps us understand whether the entire speculative sector is overheated by news of legalization.
RSI 14 for the overall market
Bright Green, a cannabis producer, sees risk appetite in this chart. During periods of euphoria, investors are willing to invest in "growth stories," ignoring losses and regulatory risks. In moments of panic, capital flees speculative, unprofitable industries, and the cash spigot for cannabis companies is shut off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BGXX (Bright Green)
Bright Green is one of the few companies in the US with a federal DEA license to cultivate cannabis for research and pharmaceutical purposes. This chart shows the analysts' average 12-month forecast. Their target price is a speculative bet on how this small legal market will develop.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BGXX-Bright-Green&v=1772641126100 "A chart showing analyst consensus forecasts for the expected stock price. BGXX (Bright Green)")
The difference between the consensus estimate and the actual stock price BGXX (Bright Green)
Bright Green (BGXX) is a "legal" supplier. The company holds a unique permit from the US DEA to cultivate cannabis for *scientific* and pharmaceutical research. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe they can monetize this unique legal status.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BGXX-Bright-Green&v=1772641126109 "A chart showing the difference between the consensus forecast and the actual stock price. BGXX (Bright Green)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Bright Green (BGXX) is one of the few companies in the US that has received a federal (DEA) license to grow cannabis for scientific and pharmaceutical research. This chart shows analysts' overall expectations for the sector. It reflects whether experts believe the FDA-approved medical cannabis market will grow.
Analysts' consensus forecast for the overall market share price
Bright Green (BGXX) is a "scientific" cannabis company. Unlike others, they have received permission from the US DEA to legally grow marijuana for *research* and pharmaceutical purposes. This chart shows the overall risk appetite, reflecting how willing investors are to invest in speculative companies in the regulatory-complex cannabis sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Bright Green
Bright Green is legal cannabis. Unlike everyone else, they are the only ones to have received federal government (DEA) approval to grow cannabis for R&D and pharmaceutical purposes (not for weed). This chart is purely an indicator of hype and R&D. It doesn't reflect revenue, but rather a speculative valuation of their (unique) license and their (as yet) unclear path to sales.
AKIMA Market Segment Index - Narco farm
Bright Green is one of the few companies in the US with a federal (DEA) license to legally grow cannabis for research and pharmaceutical purposes. It's a high-end cannabis farm. This chart compares their composite index to the sector, showing how their legal status sets them apart from their competitors.
The AKIM Index for the overall market
Bright Green is a company that has received federal approval to cultivate cannabis for research purposes in the United States. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this speculative story, which is awaiting market development, compares to overall economic trends.
